Cochlear protest shareholder vote on executive pay

Print This Post A A A

Cochlear faces the prospect of a boardroom spill in 2013 after shareholders railed against the bionic ear company’s executive pay.

About 30.85 per cent, or 10.8 million, of all votes cast by Cochlear shareholders at Tuesday’s annual general meeting were against the company’s remuneration report.

It was Cochlear’s first “strike” and under laws introduced in 2011, shareholders can call for a fresh election of directors if more than 25 per cent of eligible shareholders vote against the remuneration report for a second consecutive year in 2013.

Cochlear chairman Rick Holliday-Smith said he would take the concerns of shareholders on board.

“The mea culpa is, we will listen to everything everybody wants to say to us,” Mr Holliday-Smith told shareholders.

“We will take all that information together and we will try and come up with something that is either more explainable or better or both.

“That is what we have to do over the next 12 months.”

It was also the first “strike” of the Australian annual general meeting season.

A resolution to award chief executive Chris Roberts with $1 million worth of options passed, albeit with a sizeable 31.8 per cent no vote.

The Australian Shareholders’ Association’s representative at the meeting Stephen Mayne told the gathering the resolution was destined to fail before Mr Holliday-Smith stepped in last week to pressure institutional investors to back the motion.

“You ran a very aggressive campaign with the institutions,” Mr Mayne told Mr Holliday-Smith.

“You said this was a vote of no confidence and you strong-armed them.

“You dug in and I think that was a bit disappointing.”

In response, Mr Holliday-Smith said he met with a number of shareholders and “I thought I had a sensible dialogue with those I spoke to”.

At 1552 AEDT, Cochlear was up 96 cents at $71.83.

In August, the hearing device maker’s net profit dropped to $56.8 million in the year to June 30 from $180.1 million in 2010/11, following the mass recall of Nucleus CI500 devices.